CURE Pharmaceutical to Present at Two Virtual Events in September
September 02, 2020 08:30 ET
|
CURE Pharmaceutical Holding Corp.
- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT - - CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT - OXNARD, Calif., Sept. 02, 2020 (GLOBE...
CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
July 28, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
MOU to acquire 100% of privately held Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of...
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 15, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film...
CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements
July 08, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing...
CURE Pharmaceutical Appoints Chief Business Officer
June 16, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC: CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created...
CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition
June 09, 2020 11:22 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients,...
CURE Pharmaceutical [OTCQB:CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
June 03, 2020 07:15 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of...
CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
April 21, 2020 07:30 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339...
CURE Pharmaceutical [OTCQB:CURR] Secures Chinese Patent on its Oral Thin Films to Treat Erectile Dysfunction
March 17, 2020 08:30 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No....
CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific
February 12, 2020 07:15 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with...